McHugh Thomas S
- SEC CIK
- 0001240547
No open-market purchases or sales filed in the past year.
Current role at each company
- AVDL Avadel Pharmaceuticals PLCChief Financial Officeras of Feb 12, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McHugh Thomas S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2024 (view filing) | Dec 13 | 3 days | McHugh Thomas SChief Financial Officer | PPurchase | +2.30K | $10.44 | +$24.0K | +2.7%87.8K after | |
| Dec 12, 2024 (view filing) | Dec 11 | 1 day | McHugh Thomas SChief Financial Officer | PPurchase | +5.00K | $10.49 | +$52.5K | +6.2%85.5K after | |
| Jan 16, 2024 (view filing) | Jan 16 | Same day | McHugh Thomas SChief Financial Officer | PPurchaseADSs | +2.00K | $14.50 | +$29.0K | +2.5%80.5K after | |
| Aug 14, 2023 (view filing) | Aug 14 | Same day | McHugh Thomas SChief Financial Officer | PPurchaseADSs | +2.00K | $14.45 | +$28.9K | +2.6%78.5K after | |
| Nov 30, 2022 (view filing) | Nov 29 | 1 day | McHugh Thomas SChief Financial Officer | PPurchaseADSs | +5.00K | $7.80 | +$39.0K | +7.0%76.5K after | |
| May 31, 2022 (view filing) | May 27 | 4 days | McHugh Thomas SChief Financial Officer | PPurchaseADSs | +50.0K | $2.14 | +$107.0K | +232.6%71.5K after |